|
DFSP
MCID: DRM014
|
Dermatofibrosarcoma Protuberans malady |
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Dermatofibrosarcoma protuberans is an uncommon tumor that arises in the skin. The tumor is firm and often flesh-colored although it can be reddish, bluish, or purplish. The tumor is often found on the chest or shoulders, but it can be found on other parts of the body. Dermatofibrosarcoma protuberans may cause no symptoms, and the initial size of the tumor tends to be around 1 to 5 centimeters. This tumor has a low potential to spread to other tissues (metastasize). Treatment often involves surgery to remove the tumor, such as by Mohs’ micrographic surgery. 30
MalaCards: Dermatofibrosarcoma Protuberans, also known as DFSP, is related to bednar's tumor and fibrous histiocytoma. An important gene associated with Dermatofibrosarcoma Protuberans is PDGFB (platelet-derived growth factor beta polypeptide), and among its related pathways are Breast Cancer Regulation by Stathmin1 and Cytoskeleton remodeling_Role of PDGFs in cell migration. The drugs prednisone and prednisolone tebutate and the compounds egcg and orcein have been mentioned in the context of this disorder. Affiliated tissues include lung, breast and skin, and related mouse phenotypes are respiratory system and endocrine/exocrine gland. Genetics Home Reference: Dermatofibrosarcoma protuberans is a rare type of cancer that causes a tumor in the deep layers of skin. This condition is a type of soft tissue sarcoma, which are cancers that affect skin, fat, muscle, and similar tissues.17 Wikipedia: Dermatofibrosarcoma protuberans (DFSP) is a very rare tumor. It is a rare neoplasm of the dermis layer...44 more... |
|
Sources: 7diseasecard, 30NIH Rare Diseases, 17Genetics Home Reference, 33OMIM, 32Novoseek , 43UMLS See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for dermatofibrosarcoma protuberans Drug clinical trials:Search ClinicalTrials for dermatofibrosarcoma protuberans Search NIH Clinical Center for dermatofibrosarcoma protuberans Search CenterWatch for dermatofibrosarcoma protuberans Inferred drug relations via UMLS/NDF-RT:43 28 dexamethasone, dexamethasone acetate, dexamethasone acetate pwdr [va product], dexamethasone phosphate, dexamethasone sodium phosphate, dexamethasone sodium phosphate pwdr [va product], linolenic acid, methylprednisolone, methylprednisolone acetate, methylprednisolone sodium succinate, prednisolone, prednisolone acetate, prednisolone acetate pwdr [va product], prednisolone pwdr [va product], prednisolone sodium phosphate, prednisolone tebutate, prednisone, prednisone pwdr [va product] |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to dermatofibrosarcoma protuberans:22Lung, Breast, Skin, T cells, B cells, Endothelial, Fetal lung
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to dermatofibrosarcoma protuberans:25 (show all 25)
|
|
Sources: 35PubMed See all sources |
Articles related to dermatofibrosarcoma protuberans:(show top 50) (show all 66)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 36QIAGEN, 41Thomson Reuters, 10EMD Millipore, 34PharmGKB, 20KEGG, 3Cell Signaling Technology, 38Reactome See all sources |
Pathways related to dermatofibrosarcoma protuberans according to GeneDecks:(show all 50)
|
|
Sources: 32Novoseek , 18HMDB, 34PharmGKB, 9DrugBank, 42Tocris Bioscience See all sources |
Compounds related to dermatofibrosarcoma protuberans according to GeneDecks:(show top 50) (show all 141)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to dermatofibrosarcoma protuberans according to GeneDecks:
Biological processes related to dermatofibrosarcoma protuberans according to GeneDecks:(show all 30)
Molecular functions related to dermatofibrosarcoma protuberans according to GeneDecks:(show all 9)
|
